Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study

NCT02324595 is registered in ClinicalTrials.gov with Catholic University of the Sacred Heart as lead sponsor.

NCT NCT02324595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02324595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study
Lead sponsor
Catholic University of the Sacred Heart
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2013
Completion date
February 29, 2016
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

effects of chemotherapy, peritoneal cavity cancer, stage iv ovarian carcinoma